Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Multicenter Evaluation of ProteiOS® Allograft Derived Growth Factor in Transforaminal Lumbar Interbody Fusion (TLIF)

NCT07775729 is registered in ClinicalTrials.gov with Isto Biologics as lead sponsor.

NCT NCT07775729
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07775729 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Multicenter Evaluation of ProteiOS® Allograft Derived Growth Factor in Transforaminal Lumbar Interbody Fusion (TLIF)
Lead sponsor
Isto Biologics
Phase
Not applicable
Overall status
Not yet recruiting
Start date
December 31, 2026
Completion date
January 31, 2030
Enrollment
280 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

degenerative disc disease, lumbar spine fusion, spinal stenosis lumbar, spinal stenosis, lumbar region, spondylolisthesis, transforaminal lumbar interbody fusion